Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.093 | 0.002 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.003 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |